Evidence map›Paper›PMID 42566626›Full record

ArticleMedicine2026

Public interest trends in regenerative injections for knee osteoarthritis: A 10-year Google Trends analysis.

Hakan Uslu, Oğuzhan Çiçek, Osman Çiloğlu

Abstract read
In one paragraph

Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hakan UsluDepartment of Orthopedics and Traumatology, University of Health Sciences, Adana City Training and Research Hospital, Adana, Turkey.ORCID 0009-0003-1515-8388

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to determine public interest in intra-articular injection treatments for knee osteoarthritis (KOA) using Google Trends data. Relative search volumes (RSVs) for platelet-rich plasma (PRP), hyaluronic acid (HA), and stem cell treatments used in KOA treatment were analyzed using Google Trends data collected over the past decade (2015-2025). The annual search volume changes for each treatment were assessed using polynomial regression analysis. A subgroup analysis was performed based on the changes caused by COVID-19. The seasonal search trends were evaluated using the autoregressive integrated moving average model. Over the last 10 years, interest in the use of intra-articular injections for the treatment of KOA has increased. This increase was most pronounced in PRP. Although HA had a lower RSV than the other treatments, its trend toward a moderate increase was observed. Finally, although stem cells were the most common treatment between 2015 and 2020, their use has decreased in recent years. An increasing RSV trend was observed for PRP and HA over the past decade (R2 = 0.869, β = 7.364, P < .001; R2 = 0.880, β = 2.670, P < .001, respectively). Stem cells were the most common treatment between 2015 and 2020. They exhibited a decreasing trend in 2020 and beyond (R2 = 0.103, β = -1.002, P = .355). Seasonal analyses revealed no statistically significant differences in the number of searches across seasons. A dramatic decrease in the number of searches occurred during the COVID-19 pandemic. This decline is expected to revert to an increasing trend by 2022.

Indexed as

Hyaluronic AcidOsteoarthritis, KneePlatelet-Rich PlasmaSearch EngineStem Cell TransplantationCOVID-19HumansInjections, Intra-ArticularInternetSARS-CoV-2Hyaluronic AcidGoogle Trendshyaluronic acid injectionjoint injectionknee osteoarthritisplatelet-rich plasmastem cell therapy

Identifiers

PMID42566626
PMCPMC13456733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.